Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, replacing the previous revision.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this appears to be a minor site version update with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page shows a revision metadata update from v3.4.0 to v3.4.1 with no changes to study details or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a glossary toggle; updated footer metadata with Last Update Submitted that Met QC Criteria and Last Update Posted, adjusted No FEAR Act wording/case, and upgraded Revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedA new page revision label (v3.3.4) appears, replacing the previous revision (v3.3.3).SummaryDifference0.1%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.